Global Insight Services have recently published a report on Acne Vulgaris Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Acne Vulgaris is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. There are a different kind of causes including genetics, fluctuating hormone levels, stress, high humidity and using oily personal care products.
Request for aPDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31200
Four main factors causing acne include excess oil (sebum) production, hair follicles clogged by oil and dead skin cells, bacteria and inflammation. Other causes include fluctuating hormone levels, air pollution and certain weather conditions and some medications.
Symptoms of acne vulgaris include Whiteheads, blackheads, small red, tender bumps, pimples , large, solid, painful lumps under the skin, painful, pus-filled lumps under the skin.
Healthcare provider can diagnose acne during a skin exam. The doctor may require to confirm significant stress if the person is going through or if have a family history of acne, all of which are risk factors. Women may also be asked about their menstrual cycles.
Report Highlights
Global Insight Services, “Acne Vulgaris – Drug Pipeline Landscape, 2023” report provides an overview of the Acne Vulgaris pipeline drugs. This report covers detailed insights on Acne drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Acne pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Free customization available – https://www.globalinsightservices.com/request-customization/GIS31200
Key Players
- Accuitis, Inc,
- Akaal Pharma Pty Ltd,
- AMD Therapeutics LLC,
- Amytrx Therapeutics Inc,
- AnaptysBio, Inc.
- AOBiome LLC
- Arcutis Biotherapeutics Inc
- Ascletis Pharmaceuticals Co., Ltd
- Atacama Therapeutics Inc
- Attillaps Holdings Inc
- Bausch Health Americas, Inc
- Biofrontera Bioscience GmbH
- BioPharmX, Inc
- Botanix Pharmaceuticals
- Brystol-Myers Squibb
- Dermata Therapeutics
- Eligo Bioscience
- Hoth Therapeutics Inc
- Lee’s Pharmaceutical Limited
- Lipidor AB
- Madam Therapeutics
- Maruho Co., Ltd.
- Matrisys Bioscience Inc
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31200/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/